2-methacryloyloxyethyl phosphorylcholine and Breast Neoplasms

2-methacryloyloxyethyl phosphorylcholine has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiba, N; Ishihara, K; Jinno, H; Kitagawa, Y; Shimada, T; Ueda, M; Wada, M; Watanabe, J	1

Other Studies

1 other study(ies) available for 2-methacryloyloxyethyl phosphorylcholine and Breast Neoplasms

Article	Year
Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles. Anticancer research, 2009, Volume: 29, Issue:4 Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Delivery Systems; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Infusions, Subcutaneous; Methacrylates; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Phosphorylcholine; Tissue Distribution; Tumor Cells, Cultured	2009

Article

Year

Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.

Anticancer research, 2009, Volume: 29, Issue:4

Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Delivery Systems; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Infusions, Subcutaneous; Methacrylates; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Phosphorylcholine; Tissue Distribution; Tumor Cells, Cultured

2009